Subject: In-Practice Usage and Performance Survey of Faronem ER

Objective: A market survey for perception mapping of Faropenem ER with Urologist & Nephrologist in complicated UTI cases in daily practise.

Faronem ER tablet contains 300mg of Extended release Faropenem indicated for the treatment of complicated Urinary tract infection, Respiratory infections, Skin and soft tissue infections and gynaecological infections

Although every new product is marketed only after regulatory approval, it is important to understand how it performs in day-to-day practice of individual medical practitioners. For this purpose, we have planned a survey questionnaire to assess the real-life performance of Faropenem & perception mapping in the above-mentioned indications.

We invite you to participate in this survey and share your experience on performance of Faronem ER. All you need to do is respond to the attached questionnaire & mention your experience with Faropenem in your practise.

We are partners in promoting safe and effective drug therapy, in that spirit we hope you will give consent to participate in the study. If you do, please sign and return the enclosed consent form along with your visiting card for accuracy of records

Ms. SEEMA GHOSH
Sr. General Manager